No studies have yet explored the mechanisms by which P3H1 affects BC development, progression, and metastasis, but an algorithm-based meta-analysis of genome-wide and proteomic data identified P3H1 as a potential biomarker for CRC. Here, P3H1 is linked to colorectal carcinoma.